Viewing Study NCT05075304


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-01-04 @ 8:25 AM
Study NCT ID: NCT05075304
Status: TERMINATED
Last Update Posted: 2024-05-21
First Post: 2021-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module